Financial HealthThe company boasts a strong cash position, giving it the financial stability to fund operations well into the future without the need for immediate capital raising.
Product DevelopmentExpansion of the company's product line is on the horizon with plans to develop TB, multiplex respiratory, and HPV tests, potentially enhancing its market presence and diversifying its offerings.
Regulatory ApprovalThe company's EUA application for its innovative COVID-19 test kit is currently under FDA review, signaling potential growth as they await authorization.